Quantification of those pathological areas in percentage of the total areas examined showed that activation of Beclin-1, either by mutation at F121A or by treatment with TB-peptide, significantly reduced lung injury in response to the septic challenge (Figure 4B). The gene discussed is BECN1; the disease is tuberculosis.